Yumin Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- CAR-T cell therapy research
Papers in
-
- RNA modifications and cancer 16
- Circular RNAs in diseases 10
- Oncology 53
- CAR-T cell therapy research 11
- Co-authors
- Hao Chen (7 shared papers)Lele Miao (12 shared papers)Zhengchao Zhang (12 shared papers)Zhijian Ren (13 shared papers)Zhi‐Jian Han (2 shared papers)Xuejiao Zhu (10 shared papers)Heshui Shi (17 shared papers)Futian Tang (18 shared papers)
- Journals
- Frontiers in Oncology (12 papers)Scientific Reports (9 papers)Frontiers in Immunology (8 papers)International Journal of Oncology (5 papers)Molecular Biology Reports (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yumin Li
320 papers receiving 6.2k citations
Yumin Li's Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 971
- Oncology 1.1k
- Immunology 652
- Molecular Biology 2.0k
- Catalysis 179
Countries citing papers authored by Yumin Li
This map shows the geographic impact of Yumin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yumin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yumin Li more than expected).
Fields of papers citing papers by Yumin Li
This network shows the impact of papers produced by Yumin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yumin Li. The network helps show where Yumin Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yumin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 338 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia Hit paper breakdown → | 2021 | 393 |
| 2 | 2018 | 284 | |
| 3 | 2017 | 165 | |
| 4 | 2001 | 149 | |
| 5 | 2018 | 132 | |
| 6 | 2010 | 132 | |
| 7 | 2010 | 118 | |
| 8 | 2021 | 85 | |
| 9 | 2019 | 85 | |
| 10 | 2022 | 83 | |
| 11 | 2010 | 83 | |
| 12 | 2019 | 81 | |
| 13 | Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies. | 2019 | 77 |
| 14 | 2018 | 72 | |
| 15 | 2010 | 67 | |
| 16 | 2020 | 63 | |
| 17 | 2012 | 63 | |
| 18 | 2010 | 62 | |
| 19 | 2021 | 60 | |
| 20 | 2022 | 59 |
About Yumin Li
Yumin Li is a scholar working on Molecular Biology, Oncology, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 338 papers that have together received 6.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (20 papers), MicroRNA in disease regulation (17 papers), RNA modifications and cancer (16 papers), Helicobacter pylori-related gastroenterology studies (16 papers), Cancer-related molecular mechanisms research (13 papers), Immune Cell Function and Interaction (11 papers), CAR-T cell therapy research (11 papers) and Circular RNAs in diseases (10 papers). The work is most often cited by research in Cancer Research (971 citations), Oncology (1.1k citations), Immunology (652 citations), Molecular Biology (2.0k citations) and Catalysis (179 citations). Yumin Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Hao Chen, Lele Miao, Zhengchao Zhang, Zhijian Ren, Zhi‐Jian Han, Xuejiao Zhu, Heshui Shi, Futian Tang, Wenting He and Xiaoyu Han. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, International Journal of Oncology and Molecular Biology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.